Plasma levels of TGF-βs are elevated in patients with breast cancer whereas after surgical removal of the primary tumor, highly expressed TGF-β1 levels normalize in the majority of patients [33, 34]. This evidence concerns the gene TGFB1 and breast carcinoma.